Sven Luettke

Person

Ockenheim, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds and methods for treating urinary incontinence
- Patent number 7,019,021
- Issue date Mar 28, 2006
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Franz Esser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods for treating urinary incontinence
- Patent number 6,858,594
- Issue date Feb 22, 2005
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Franz Esser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing a scopine ester intermediate
- Patent number 6,506,900
- Issue date Jan 14, 2003
- Boehringer Ingelheim Pharma AG
- Rolf Banholzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing an anticholinergic
- Patent number 6,486,321
- Issue date Nov 26, 2002
- Boehringer Ingelheim Pharma KG
- Rolf Banholzer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing guanidine and amidine derivatives
- Patent number 6,455,700
- Issue date Sep 24, 2002
- Boehringer Ingelheim Pharma KG
- Sven Luettke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes and intermediate compounds for preparing guanidine and am...
- Patent number 6,429,328
- Issue date Aug 6, 2002
- Boehringer Ingelheim Pharma KG
- Sven Luettke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neurokinin antagonists, processes for preparing them and pharmaceut...
- Patent number 6,277,840
- Issue date Aug 21, 2001
- Boehringer Ingelheim Pharma KG
- Franz Esser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of urinary incontinence by administration of α1L-a...
- Patent number 6,268,389
- Issue date Jul 31, 2001
- Boehringer Ingelheim KG
- Franz Esser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neurokinin antagonists, processes for preparing them and pharmaceut...
- Patent number 6,103,719
- Issue date Aug 15, 2000
- Boehringer Ingelheim Pharma KG
- Franz Esser
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Compounds and methods for treating urinary incontinence
- Publication number 20040198796
- Publication date Oct 7, 2004
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Franz Esser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Intermediate compound for preparing guanidine and amidine derivatives
- Publication number 20020147359
- Publication date Oct 10, 2002
- Sven Luettke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for preparing guanidine and amidine derivatives
- Publication number 20020133012
- Publication date Sep 19, 2002
- Sven Luettke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for preparing an anticholinergic
- Publication number 20020133010
- Publication date Sep 19, 2002
- Rolf Banholzer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Processes and intermediate compounds for preparing guanidine and am...
- Publication number 20020010173
- Publication date Jan 24, 2002
- Sven Luettke
- C07 - ORGANIC CHEMISTRY

Sven Luettke

Person

Patents Grantslast 30 patents

Compounds and methods for treating urinary incontinence

Compounds and methods for treating urinary incontinence

Process for preparing a scopine ester intermediate

Process for preparing an anticholinergic

Process for preparing guanidine and amidine derivatives

Processes and intermediate compounds for preparing guanidine and am...

Neurokinin antagonists, processes for preparing them and pharmaceut...

Treatment of urinary incontinence by administration of &#x03B1;1L-a...

Neurokinin antagonists, processes for preparing them and pharmaceut...

Patents Applicationslast 30 patents

Compounds and methods for treating urinary incontinence

Intermediate compound for preparing guanidine and amidine derivatives

Process for preparing guanidine and amidine derivatives

Process for preparing an anticholinergic

Processes and intermediate compounds for preparing guanidine and am...

Treatment of urinary incontinence by administration of α1L-a...